Allspring Global Investments Holdings LLC decreased its holdings in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 25.0% during the fourth quarter, according to its most recent filing with the ...

At AGBT, Singular Genomics presented data demonstrating the G4X platform’s robust integrated multiomic performance. Immune-oncology-focused lung, kidney, colon, and breast panels showed high ...

Ultima Genomics, Inc., a developer of an ultra-high-throughput sequencing architecture, today announced the commercial launch of UG 100 Solaris at the Advances in Genome Biology and Technology (AGBT) ...

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.

We recently published a list of 12 Best Scientific Instruments Stocks to Buy Right Now. In this article, we are going to take ...

Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...

Learn more about whether LeMaitre Vascular, Inc. or Neogen Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

On December 23, 2024, Singular Genomics announced that Deerfield had signed a definitive agreement to acquire all of the outstanding shares of Singular Genomics common stock not currently owned by ...